A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Weekly and Every Other Week Dosing Regimens of Iduronate-2-Sulfatase Enzyme Replacement Therapy in Patients With MPS II
收藏DataCite Commons2025-05-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00006844/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to determine whether the administration of iduronate-2-sulfatase
enzyme in a weekly or every other week therapy frequency is safe and efficacious in patients
with MPS II.
提供机构：
Vivli
创建时间：
2021-04-07
